Forskning ved Københavns Universitet - Københavns Universitet

Forside

Biofarmaka til behandling af reumatoid artritis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

The current status on the use of biopharmaceuticals in the treatment of rheumatoid arthritis is reviewed. Blocking of TNF-alpha, co-stimulation of CD28+ T-cells and depletion of CD20+ B-cells are all effective ways to diminish inflammation and joint damage. However, not all patients react to these treatments, and the development of biomarkers to predict which patients will benefit from these drugs is therefore warranted.
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind170
Udgave nummer24
Sider (fra-til)2108-10
Antal sider3
ISSN0041-5782
StatusUdgivet - 9 jun. 2008

ID: 34078180